Société scientifique de médecine générale d'Expression française
0410.639.602 · rovalta.com · 27/09/2026
Société scientifique de médecine générale d'Expression française
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOSociété scientifique de médecine générale d'Expression française is a Non-profit organization incorporated in 1968. Its main activity is: Manufacture of rubber products. Its registered office is in Saint-Gilles. It employs on average 9,7 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0410.639.602
- Incorporation
- 31/10/1968
- Legal form
- Non-profit organization
- Registered office
- Rue de Suisse 8
1060 Saint-Gilles · BruxellesSee on map - Latest accounts
- 31/12/2025
- Average workforce
- 9,7 ETP
Joint committees (1)
- 32902
Financials
Source · NBB, 18 filingsTrend over 16 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 893,5 k € | +10.5% | 808,3 k € | -15.2% | 952,7 k € | -12.6% | 1,1 M € | +27.3% | 856,8 k € |
| EBITDA | 237,9 k € | +184% | 83,9 k € | -61.4% | 217,3 k € | -52.3% | 455,2 k € | +38.2% | 329,4 k € |
| Operating result | 188,7 k € | +1127% | 15,4 k € | -89.4% | 144,7 k € | -62.4% | 384,6 k € | +42.2% | 270,5 k € |
| Net result | 199,2 k € | +857% | 20,8 k € | -84.1% | 131 k € | -65.0% | 374,1 k € | +28.8% | 290,5 k € |
| Balance sheet | |||||||||
| Equity | 3,1 M € | +6.8% | 2,9 M € | +0.7% | 2,9 M € | +4.7% | 2,8 M € | +15.7% | 2,4 M € |
| Total assets | 3,7 M € | +8.7% | 3,4 M € | -3.3% | 3,5 M € | +0.9% | 3,4 M € | +19.4% | 2,9 M € |
| Cash | 875,4 k € | +39.9% | 625,7 k € | -15.3% | 738,4 k € | +2.1% | 723,3 k € | -69.2% | 2,3 M € |
| Debts | 235,9 k € | +18.3% | 199,4 k € | -15.1% | 235 k € | -18.8% | 289,3 k € | +64.1% | 176,3 k € |
| Other | |||||||||
| Workforce | 9,7 ETP | +4.3% | 9,3 ETP | +2.2% | 9,1 ETP | +8.3% | 8,4 ETP | +6.3% | 7,9 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/202517 active · 106 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Alberto PARADA | Director | 22/03/2025 → 22/03/2029 | 000 |
AURORE GIRARD | Director | 22/03/2025 → 22/03/2029 | 000 |
CATHERINE LIETAER | Director | 22/03/2025 → 22/03/2029 | |
GILLES COLEMONTS | Director | 22/03/2025 → 22/03/2029 | 000 |
GUY BEUKEN | Director | 22/03/2025 → 22/03/2029 | 00 |
HANNA BALLOUT | Director | 22/03/2025 → 22/03/2029 | 000 |
Jean-Philippe AGELAS | Director | 22/03/2025 → 22/03/2029 | |
MARTHE KNOPS | Director | 22/03/2025 → 22/03/2029 | 000 |
SOPHIE KUTZNER | Director | 22/03/2025 → 22/03/2029 | |
VIRGINIE DE RIDDER | Director | 22/03/2025 → 22/03/2029 | |
Imane HAFID | Director | 16/03/2024 → 15/03/2028 | |
Sarah CUMPS | Director | 16/03/2024 → 15/03/2028 | 000 |
JEAN-FRANCOIS ROCHET | Director | 18/03/2023 → 18/03/2027 | 00 |
Jean-Marie LEDOUX | Director | 18/03/2023 → 18/03/2027 | 000 |
SEBAHAT DERSAN | Director | 18/03/2023 → 18/03/2027 | |
SONIA GOUDJIL | Director | 18/03/2023 → 18/03/2027 | |
Thomas JACOB | Director | 18/03/2023 → 18/03/2027 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Jean-Philippe AGELAS | Director | 18/03/2024 → 17/03/2025 | |
Juan Pedro HERNANDEZ PUJANTE | Director | 18/03/2023 → 18/03/2027 | |
Juan Pedro HERNANDEZ PUJANTE | Director | 31/03/2022 → 18/03/2023 | |
GILLES COLEMONTS | Director | 30/06/2021 → 29/06/2025 | 000 |
Other companies at this address
Rue de Suisse 8 1060 Saint-Gilles| Company | CBE no. |
|---|---|
| 0824.647.280 | |
| 0465.534.078 | |
| 0715.399.744 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 06/08/2026 | 17/05/2025 | 03/10/2024 | 27/03/2023 | 05/05/2022 | 26/03/2021 |
| General meeting | 28/03/2026 | 22/03/2025 | 16/03/2024 | 18/03/2023 | 31/03/2022 | 02/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 18 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 28/03/2026 | 06/08/2026 | French | |
| Abridged model | 31/12/2024 | 22/03/2025 | 17/05/2025 | French | |
| Abridged model | 31/12/2023 | 16/03/2024 | 03/10/2024 | French | |
| Abridged model | 31/12/2022 | 18/03/2023 | 27/03/2023 | French | |
| Abridged model | 31/12/2021 | 31/03/2022 | 05/05/2022 | French | |
| Abridged model | 31/12/2020 | 02/03/2021 | 26/03/2021 | French | |
| Abridged model | 31/12/2019 | 15/02/2020 | 12/03/2020 | French | |
| Abridged model | 31/12/2018 | 23/02/2019 | 02/07/2019 | French | |
| Abridged model | 31/12/2017 | 24/02/2018 | 19/06/2018 | French | |
| Abridged modelCorrection | 31/12/2016 | 25/03/2017 | 29/03/2018 | French | |
| Abridged model | 31/12/2016 | 25/03/2017 | 29/06/2017 | French | |
| Abridged model | 31/12/2015 | 19/02/2016 | 07/03/2016 | French | |
| Abridged model | 31/12/2014 | 28/02/2015 | 27/05/2015 | French | |
| Abridged model | 31/12/2013 | 15/03/2014 | 26/08/2014 | French | |
| Abridged model | 31/12/2012 | 14/03/2013 | 20/08/2013 | French | |
| Abridged model | 31/12/2011 | 10/03/2012 | 13/06/2012 | French | |
| Abridged model | 31/12/2010 | 26/02/2011 | 13/04/2011 | French | |
| Abridged model | 31/12/2007 | 25/10/2008 | 08/12/2008 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/202517 active · 106 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Alberto PARADA | Director | 22/03/2025 → 22/03/2029 | 000 |
AURORE GIRARD | Director | 22/03/2025 → 22/03/2029 | 000 |
CATHERINE LIETAER | Director | 22/03/2025 → 22/03/2029 | |
GILLES COLEMONTS | Director | 22/03/2025 → 22/03/2029 | 000 |
GUY BEUKEN | Director | 22/03/2025 → 22/03/2029 | 00 |
HANNA BALLOUT | Director | 22/03/2025 → 22/03/2029 | 000 |
Jean-Philippe AGELAS | Director | 22/03/2025 → 22/03/2029 | |
MARTHE KNOPS | Director | 22/03/2025 → 22/03/2029 | 000 |
SOPHIE KUTZNER | Director | 22/03/2025 → 22/03/2029 | |
VIRGINIE DE RIDDER | Director | 22/03/2025 → 22/03/2029 | |
Imane HAFID | Director | 16/03/2024 → 15/03/2028 | |
Sarah CUMPS | Director | 16/03/2024 → 15/03/2028 | 000 |
JEAN-FRANCOIS ROCHET | Director | 18/03/2023 → 18/03/2027 | 00 |
Jean-Marie LEDOUX | Director | 18/03/2023 → 18/03/2027 | 000 |
SEBAHAT DERSAN | Director | 18/03/2023 → 18/03/2027 | |
SONIA GOUDJIL | Director | 18/03/2023 → 18/03/2027 | |
Thomas JACOB | Director | 18/03/2023 → 18/03/2027 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Jean-Philippe AGELAS | Director | 18/03/2024 → 17/03/2025 | |
Juan Pedro HERNANDEZ PUJANTE | Director | 18/03/2023 → 18/03/2027 | |
Juan Pedro HERNANDEZ PUJANTE | Director | 31/03/2022 → 18/03/2023 | |
GILLES COLEMONTS | Director | 30/06/2021 → 29/06/2025 | 000 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates15/06/2026DEMISSIONS, NOMINATIONS
- Mandates08/05/2025DEMISSIONS, NOMINATIONS
- Mandates10/06/2024DEMISSIONS, NOMINATIONS
- Mandates25/04/2023DEMISSIONS, NOMINATIONS
- Mandates14/03/2023DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates30/09/2022DEMISSIONS, NOMINATIONS
- Mandates10/11/2021DEMISSIONS, NOMINATIONS
- Mandates30/06/2021DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025199,2 k €↑
- 2024Annual accounts 202420,8 k €↓
- 2023Annual accounts 2023131 k €↓
- 2022Annual accounts 2022374,1 k €↑
- 2021Annual accounts 2021290,5 k €↑
- 2021Name changeS.S.M.G.
- 2020Annual accounts 2020190,6 k €↓
- 2019Annual accounts 2019321,6 k €↑
- 2018Annual accounts 201857,9 k €↓
- 2017Annual accounts 2017134,7 k €↑
- 2016Annual accounts 2016-1,2 k €↓
- 2015Annual accounts 201549,8 k €↓
- 2014Annual accounts 201498,7 k €↑
- 2013Annual accounts 201377,4 k €↓
- 2012Annual accounts 2012107,6 k €↑
- 2011Annual accounts 201151,2 k €↓
- 2010Annual accounts 201066,3 k €
- 31/10/1968IncorporationNon-profit organization
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Société scientifique de médecine générale d'Expression françaiseCurrent | CBE, tracked since 27/09/2026 | CBE |
| S.S.M.G. | accounts 2021 → 2025 | Accounts 2025 · 2026-00391020 |
| Société scientifique de médecine générale d'Expression française | accounts 2010 → 2020 | Accounts 2020 · 2021-08700542 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.